Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stergios A Polyzos

Showing results (51-60 of 431) with videos related to

Pageof 44
Sort By:
Current Medical Research and Opinion|March 30, 2022
Metreleptin for the treatment of lipodystrophy: leading the way among novel therapeutics for this unmet clinical needStergios A Polyzos, Christos S Mantzoros
Metabolism: Clinical and Experimental|July 25, 2020
Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)Stergios A Polyzos, Christos S Mantzoros
Maturitas|May 17, 2024
Menopause and metabolic dysfunction-associated steatotic liver diseaseStergios A Polyzos, Dimitrios G Goulis
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2015
Helicobacter pylori Associated With Obstructive Sleep Apnea Might Contribute to Sleep, Cognition, and Driving Performance Disturbances in Patients With CirrhosisJannis Kountouras, Stergios A Polyzos, Georgia Deretzi
European Journal of Pharmacology|September 20, 2019
Farnesoid X nuclear receptor agonists for the treatment of nonalcoholic steatohepatitisVasiliki Venetsanaki, Zacharoula Karabouta, Stergios A Polyzos
Digestive Diseases (Basel, Switzerland)|February 12, 2025
Helicobacter pylori Infection and Metabolic Dysfunction-Associated Steatotic Liver DiseaseStergios A Polyzos, Nikoletta Pyrrou, Jannis Kountouras
Archives of Medical Research|December 18, 2020
Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver DiseaseEvangelia Makri, Antonis Goulas, Stergios A Polyzos
Hormones (Athens, Greece)|August 21, 2007
Thyroid nodules - stepwise diagnosis and managementStergios A Polyzos, Marina Kita, Avraam Avramidis
Current Molecular Medicine|April 10, 2009
Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokinesStergios A Polyzos, Jannis Kountouras, Christos Zavos
Diagnostic Cytopathology|March 24, 2009
Histological alterations following thyroid fine needle biopsy: a systematic reviewStergios A Polyzos, Kalliopi Patsiaoura, Konstantia Zachou
Pageof 44

Showing results (51-60 of 431) with videos related to

Sort By:
Pageof 44
Current Medical Research and Opinion|March 30, 2022
Metreleptin for the treatment of lipodystrophy: leading the way among novel therapeutics for this unmet clinical needStergios A Polyzos, Christos S Mantzoros
Metabolism: Clinical and Experimental|July 25, 2020
Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)Stergios A Polyzos, Christos S Mantzoros
Maturitas|May 17, 2024
Menopause and metabolic dysfunction-associated steatotic liver diseaseStergios A Polyzos, Dimitrios G Goulis
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 21, 2015
Helicobacter pylori Associated With Obstructive Sleep Apnea Might Contribute to Sleep, Cognition, and Driving Performance Disturbances in Patients With CirrhosisJannis Kountouras, Stergios A Polyzos, Georgia Deretzi
European Journal of Pharmacology|September 20, 2019
Farnesoid X nuclear receptor agonists for the treatment of nonalcoholic steatohepatitisVasiliki Venetsanaki, Zacharoula Karabouta, Stergios A Polyzos
Digestive Diseases (Basel, Switzerland)|February 12, 2025
Helicobacter pylori Infection and Metabolic Dysfunction-Associated Steatotic Liver DiseaseStergios A Polyzos, Nikoletta Pyrrou, Jannis Kountouras
Archives of Medical Research|December 18, 2020
Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver DiseaseEvangelia Makri, Antonis Goulas, Stergios A Polyzos
Hormones (Athens, Greece)|August 21, 2007
Thyroid nodules - stepwise diagnosis and managementStergios A Polyzos, Marina Kita, Avraam Avramidis
Current Molecular Medicine|April 10, 2009
Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokinesStergios A Polyzos, Jannis Kountouras, Christos Zavos
Diagnostic Cytopathology|March 24, 2009
Histological alterations following thyroid fine needle biopsy: a systematic reviewStergios A Polyzos, Kalliopi Patsiaoura, Konstantia Zachou
Pageof 44